301246 宏源藥業
按盤價 
20.480 +2.690 (+15.121%)
20.480 +2.690 (+15.121%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -0.025 | 1.180 | 2.693 | 22.933 | 34.508 |
| 總資產報酬率 ROA (%) | -0.019 | 0.897 | 1.830 | 13.786 | 23.607 |
| 投入資產回報率 ROIC (%) | -0.021 | 1.012 | 2.144 | 17.436 | 29.964 | 邊際利潤分析 |
| 銷售毛利率 (%) | 12.712 | 12.185 | 12.987 | 23.324 | 33.635 |
| 營業利潤率 (%) | 0.501 | 3.391 | 5.141 | 23.256 | 34.758 |
| 息稅前利潤/營業總收入 (%) | 0.877 | 3.203 | 4.631 | 22.630 | 34.808 |
| 淨利潤/營業總收入 (%) | -0.148 | 2.906 | 4.242 | 21.069 | 31.299 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 466.504 | 97.242 | 90.912 | 66.078 | 65.527 |
| 價值變動淨收益/利潤總額(%) | 5.975 | 11.510 | 22.606 | 35.567 | 34.909 |
| 營業外收支淨額/利潤總額(%) | -27.085 | -0.593 | -7.190 | -0.410 | -0.622 | 償債能力分析 |
| 流動比率 (X) | 2.913 | 2.682 | 3.500 | 1.261 | 1.667 |
| 速動比率 (X) | 2.646 | 2.444 | 3.291 | 0.994 | 1.044 |
| 資產負債率 (%) | 26.533 | 25.130 | 22.845 | 45.453 | 31.011 |
| 帶息債務/全部投入資本 (%) | 16.427 | 12.843 | 11.754 | 28.092 | 7.396 |
| 股東權益/帶息債務 (%) | 497.409 | 663.789 | 733.974 | 244.423 | 1,188.820 |
| 股東權益/負債合計 (%) | 276.866 | 297.906 | 337.728 | 120.007 | 222.464 |
| 利息保障倍數 (X) | 1.819 | -19.111 | -28.042 | -42.601 | 131.159 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 55.077 | 45.439 | 45.928 | 39.143 | 27.248 |
| 存貨周轉天數 (天) | 65.529 | 53.485 | 54.810 | 83.884 | 125.130 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 23/12/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
